EssilorLuxottica stock stays supported by record half-year sales
Published on 09/06/2026 at 12:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
EssilorLuxottica stock stays supported by its half-year 2026 performance, with revenue of EUR 14.02 billion and EBIT of EUR 2.10 billion for the six months ended June 30, 2026.
Half-year growth holds up
The group reported EUR 14.02 billion in revenue for H1 2026, while EBIT reached EUR 2.10 billion and margin held at 15.0 percent. Those figures compare with the same half-year period in 2025 and give investors a clean view of the operating base heading into the second half of 2026.
Net profit came in at EUR 1.41 billion in H1 2026, and diluted EPS was EUR 3.19. The combination of EUR 14.02 billion in sales and EUR 1.41 billion in profit is the most important recent signal for the stock.
Margin is the key
For investors, the 15.0 percent EBIT margin matters as much as the top line. It shows how much of the EUR 14.02 billion in first-half sales converted into operating profit, and it gives a reference point for the rest of fiscal 2026.
Historical context also matters: in H1 2025, revenue was EUR 13.18 billion and EBIT was EUR 1.98 billion. That means revenue rose by EUR 0.84 billion year on year, while EBIT increased by EUR 0.12 billion.
EssilorLuxottica half-year figures in full
The half-year report gives the clearest current read on sales, profit and margin for fiscal 2026.
Eyewear still drives demand
EssilorLuxottica sells prescription lenses, optical instruments and eyewear through brands and retail channels that keep recurring demand visible. That product mix is what makes the H1 2026 numbers relevant for the share, not just the headline revenue.
The stock line can be read through the business mix: EUR 14.02 billion in first-half revenue, EUR 2.10 billion in EBIT and EUR 1.41 billion in net profit leave little doubt that profitability remains the main variable.
Price and market view
Price, market capitalization and volume were not available from the search results used for this article, so the most recent substantiated market view comes from the reported H1 2026 figures above. The stock is listed in Paris under the ISIN FR0000121667.
EssilorLuxottica stock facts
- Company: EssilorLuxottica SE
- ISIN: FR0000121667
- Ticker: EL
- Trading venue: Euronext Paris
- Sector / Industry: Health Care / Health Care Equipment and Supplies
- Index membership: CAC 40
